title: Biocon's first-in-class anti-CD6 mAb reaches the market.
authors: Killugudi
authors: K
authors: Jayaraman
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D017277:Drug Approval; D004345:Drug Industry / Q000458:organization & administration*; D006801:Humans; D007194:India; D040541:Marketing / Q000458:organization & administration*; D011565:Psoriasis / Q000188:drug therapy*
chemical_list: D000911:Antibodies, Monoclonal